{"id":"W2065301637","doi":"10.1016/j.eplepsyres.2012.05.007","title":"Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies","year":2012,"lang":"en","type":"article","venue":"Epilepsy Research","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; GlaxoSmithKline","keywords":"Tolerability; Medicine; Open label; Somnolence; Anesthesia; Refractory (planetary science); Epilepsy; Anticonvulsant; Adverse effect; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004311539,0.0003355045,0.0009733536,0.0005083263,0.0002133219,0.00005273558,0.0003981817,0.0001316643,0.000121724],"category_scores_gemma":[0.003966978,0.0002356775,0.00005019284,0.0008673586,0.0009055188,0.0003989108,0.0009151041,0.001097498,0.00007414732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000372203,"about_ca_system_score_gemma":0.0004011259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003436278,"about_ca_topic_score_gemma":0.001199547,"domain_scores_codex":[0.9948657,0.0009538052,0.000872292,0.0007812909,0.001255818,0.001271167],"domain_scores_gemma":[0.9940206,0.003500519,0.0001672664,0.001008322,0.0005797668,0.000723524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1696342,0.007833766,0.7409743,0.0006653068,0.00141795,0.0009840685,0.02030125,0.000005667006,0.002818233,0.0003161588,0.005622296,0.04942676],"study_design_scores_gemma":[0.132721,0.01491123,0.8122956,0.009489444,0.0001533327,0.0001159405,0.0101308,0.0002802194,0.009353483,0.0001726848,0.00971634,0.0006598863],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864405,0.006322,0.000005699455,0.002090416,0.00008081575,0.002023881,0.0002461634,0.00003535059,0.00275514],"genre_scores_gemma":[0.9915655,0.005335084,0.001401231,0.00005477269,0.0002786068,0.0001335701,0.0002612799,0.0000570426,0.0009129653],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0713213,"threshold_uncertainty_score":0.9610649,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.136092806450146,"score_gpt":0.4441202531045085,"score_spread":0.3080274466543625,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}